We also demonstrate that one of the degradation mechanisms of AXL is associated with PS-RIP, and thus, enhancing the degradation of AXL can effectively inhibit cell proliferation and tumor growth in NSCLC and EGFR-TKI-resistant NSCLC cells. Here, EGFR is linked to neoplasm.